CAR-T cells have been developed against EGFR (EGF-CAR-T) using the piggyBac system, and they showed a potent antitumor activity against non-small-cell lung cancer (NSCLC) cell lines in vitro and in vivo in NSG mice [62]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.